Reported Consolidated quarterly numbers for Panacea Biotec are:
Net Sales at Rs 132.53 crore in March 2025 down 2.88% from Rs. 136.46 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 1.89 crore in March 2025 down 32.17% from Rs. 1.43 crore in March 2024.
EBITDA stands negative at Rs. 18.29 crore in March 2025 down 483.44% from Rs. 4.77 crore in March 2024.
Panacea Biotec shares closed at 504.00 on May 30, 2025 (NSE) and has given 7.99% returns over the last 6 months and 288.74% over the last 12 months.
Story continues below Advertisement
| Panacea Biotec | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 132.53 | 163.49 | 136.46 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 132.53 | 163.49 | 136.46 | | EXPENDITURE | | Consumption of Raw Materials | 83.32 | 48.74 | 45.53 | | Purchase of Traded Goods | 7.45 | 0.15 | -0.49 | | Increase/Decrease in Stocks | -38.69 | 13.66 | 4.71 | | Power & Fuel | -- | -- | -- | | Employees Cost | 49.13 | 42.98 | 38.43 | | Depreciation | 8.42 | 8.98 | 8.81 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 58.20 | 50.00 | 54.32 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -35.30 | -1.02 | -14.85 | | Other Income | 8.59 | 3.62 | 10.81 | | P/L Before Int., Excpt. Items & Tax | -26.71 | 2.60 | -4.04 | | Interest | 1.04 | 0.99 | 0.82 | | P/L Before Exceptional Items & Tax | -27.75 | 1.61 | -4.86 | | Exceptional Items | 27.71 | 2.77 | 2.74 | | P/L Before Tax | -0.04 | 4.38 | -2.12 | | Tax | 1.95 | -0.06 | -0.13 | | P/L After Tax from Ordinary Activities | -1.99 | 4.44 | -1.99 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.99 | 4.44 | -1.99 | | Minority Interest | 0.10 | 0.08 | 0.56 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -1.89 | 4.52 | -1.43 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.31 | 0.74 | -0.23 | | Diluted EPS | -0.31 | 0.74 | -0.23 | | EPS After Extra Ordinary | | Basic EPS | -0.31 | 0.74 | -0.23 | | Diluted EPS | -0.31 | 0.74 | -0.23 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
